{"organizations": [], "uuid": "ef0b690f92b13d79ac9d4ae5cea9e1a0d8c39cc4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-actinium-pharmaceuticals-amends-pr/brief-actinium-pharmaceuticals-amends-pricing-terms-of-rights-offering-idUSASB0C7G9", "country": "US", "domain_rank": 408, "title": "BRIEF-Actinium Pharmaceuticals Amends Pricing Terms Of Rights Offering", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-26T17:15:00.000+02:00", "replies_count": 0, "uuid": "ef0b690f92b13d79ac9d4ae5cea9e1a0d8c39cc4"}, "author": "", "url": "https://www.reuters.com/article/brief-actinium-pharmaceuticals-amends-pr/brief-actinium-pharmaceuticals-amends-pricing-terms-of-rights-offering-idUSASB0C7G9", "ord_in_thread": 0, "title": "BRIEF-Actinium Pharmaceuticals Amends Pricing Terms Of Rights Offering", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "rights offering reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "reuters) - actinium pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 26, 2018 / 3:17 PM / Updated 4 minutes ago BRIEF-Actinium Pharmaceuticals Amends Pricing Terms Of Rights Offering Reuters Staff 1 Min Read Feb 26 (Reuters) - Actinium Pharmaceuticals Inc: * ACTINIUM PHARMACEUTICALS REITERATES PREVIOUSLY ANNOUNCED EXPIRATION DATE OF MARCH 2, 2018 AT 5:00 PM ET AND AMENDMENT TO PRICING TERMS OF ITS RIGHTS OFFERING * SAYS ‍PRICING OF UNITS AMENDED TO $0.50/UNIT WITH CORRESPONDING AMENDMENTS TO WARRANT EXERCISE PRICES​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-26T17:15:00.000+02:00", "crawled": "2018-02-26T17:26:06.053+02:00", "highlightTitle": ""}